Price Alert

Lifecore Biomedical Inc. (LFCR)

NASDAQ: LFCR · Real-Time Price · USD

7.01

0.20 (2.94%)

At close: Sep 26, 2025, 3:59 PM

7.15

2.00%

After-hours: Sep 26, 2025, 05:32 PM EDT

Lifecore Biomedical Statistics

Share Statistics

Lifecore Biomedical has 37.4M shares outstanding. The number of shares has increased by 19.96% in one year.

Shares Outstanding	37.4M
Shares Change (YoY)	19.96%
Shares Change (QoQ)	0%
Owned by Institutions (%)	66.21%
Shares Floating	33.54M
Failed to Deliver (FTD) Shares	32
FTD / Avg. Volume	0.02%

Short Selling Information

The latest short interest is 2.65M, so 7.09% of the outstanding shares have been sold short.

Short Interest	2.65M
Short % of Shares Out	7.09%
Short % of Float	12.39%
Short Ratio (days to cover)	15.78

Valuation Ratios

The PE ratio is -6.04 and the forward PE ratio is -9.46. Lifecore Biomedical's PEG ratio is 0.01.

PE Ratio	-6.04
Forward PE	-9.46
PS Ratio	1.82
Forward PS	2
PB Ratio	4.93
P/FCF Ratio	-17.18
PEG Ratio	0.01

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Lifecore Biomedical.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.84, with a Debt / Equity ratio of 2.79.

Current Ratio	2.84
Quick Ratio	1.77
Debt / Equity	2.79
Debt / EBITDA	-3.41
Debt / FCF	-9.7
Interest Coverage	-1.77

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$245.93K
Profits Per Employee	$-73.89K
Employee Count	524
Asset Turnover	0.54
Inventory Turnover	2.74

Taxes

Income Tax	43K
Effective Tax Rate	-0.11%

Stock Price Statistics

The stock price has increased by 41.62% in the last 52 weeks. The beta is 0.64, so Lifecore Biomedical's price volatility has been higher than the market average.

Beta	0.64
52-Week Price Change	41.62%
50-Day Moving Average	7.46
200-Day Moving Average	6.89
Relative Strength Index (RSI)	41.5
Average Volume (20 Days)	173,530

Income Statement

In the last 12 months, Lifecore Biomedical had revenue of 128.87M and earned -38.72M in profits. Earnings per share was -1.27.

Revenue	128.87M
Gross Profit	40.3M
Operating Income	-38.72M
Net Income	-38.72M
EBITDA	-38.72M
EBIT	-16.84M
Earnings Per Share (EPS)	-1.27

Full Income Statement

Balance Sheet

The company has 8.27M in cash and 132.17M in debt, giving a net cash position of -123.9M.

Cash & Cash Equivalents	8.27M
Total Debt	132.17M
Net Cash	-123.9M
Retained Earnings	-205.24M
Total Assets	239.34M
Working Capital	55.5M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -206K and capital expenditures -13.41M, giving a free cash flow of -13.62M.

Operating Cash Flow	-206K
Capital Expenditures	-13.41M
Free Cash Flow	-13.62M
FCF Per Share	-0.39

Full Cash Flow Statement

Margins

Gross margin is 31.27%, with operating and profit margins of -30.04% and -30.04%.

Gross Margin	31.27%
Operating Margin	-30.04%
Pretax Margin	-30.01%
Profit Margin	-30.04%
EBITDA Margin	-30.04%
EBIT Margin	-30.04%
FCF Margin	-10.57%

Dividends & Yields

LFCR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for LFCR is $8, which is 14.1% higher than the current price. The consensus rating is "Hold".

Price Target	$8
Price Target Difference	14.1%
Analyst Consensus	Hold
Analyst Count	4

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	0.31
Piotroski F-Score	3